Limited growth of severed CNS axons after treatment of adult rat brain with hyaluronidase
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Many chondroitin sulfate proteoglycans (CSPGs) have been shown to influence CNS axon growth in vitro and in vivo. These interactions can be mediated through the core protein or through the chondroitin sulfate (CS) glycosaminoglycan (GAG) side chains. We have shown previously that degrading CS GAG side chains using chondroitinase ABC enhances dopaminergic nigrostriatal axon regeneration in vivo. We test the hypothesis that interfering with complete CSPGs also limit axon growth in vivo. Neurocan, versican, aggrecan, and brevican CSPGs may be anchored within extracellular matrix through binding to hyaluronan glycosaminoglycan. We examine whether degradation of hyaluronan using hyaluronidase might release these inhibitory CSPGs from the extracellular matrix and thereby enhance regeneration of cut nigrostriatal axons. Anesthetized adult rats were given knife cut lesions of the right hemisphere nigrostriatal tract and cannulae were secured transcranially thereby allowing repeated perilesional infusion of saline or saline containing hyaluronidase once daily for 10 days post‐axotomy. Eleven days post‐transection brains from animals under terminal anesthesia were recovered for histological evaluation. Effective delivery of substance was inferred from the observed reduction in perilesional immunoreactivity for neurocan and versican after treatment with hyaluronidase (relative to saline). Immunolabeling using antibodies against tyrosine hydroxylase was used to examine the response of cut dopaminergic nigral neurons. After transection and treatment with saline, dopaminergic nigral neurons sprouted in a region lacking astrocytes, neurocan and versican. Axons did not regenerate into the lesion surround that contained astrocytes and abundant neurocan and versican. After transection and treatment with hyaluronidase, there was a significant increase in the number of cut dopaminergic nigral axons growing up to 800 μm anterior to the site of transection. However, cut dopaminergic nigral axons still did not regenerate into the lesion surround that contained reduced (albeit residual) neurocan and versican immunoreactivity. Thus, partial degradation of hyaluronan and chondroitin sulfate and depletion of hyaluronan‐binding CSPGs enhances local sprouting of cut CNS axons, but long‐distance regeneration fails in regions containing residual hyaluronan‐binding CSPGs. Hyaluronan, chondroitin sulfate and hyaluronan‐binding CSPGs therefore likely contribute toward the failure of spontaneous axon regeneration in the injured adult mammalian brain and spinal cord. © 2002 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chondroitinase ABC promotes functional recovery after spinal cord injury
Bradbury, E. J., Moon, L. D. F., Popat, R. J., King, V. R., Bennett, G. S., Patel, P. N., Fawcett, J. W., & McMahon, S. B. (2002) · Nature · doi:10.1038/416636a · Cited by 2,357 · cited 2×
“…et al., 1997; Fidler et al., 1999; Niederöst et al., 1999), disrupts axon guidance in the embryo (Chung et al., 2000), enhances growth of CNS neurons into peripheral nerve implants (Yick et al., 2000) and enhances regeneration of cut CNS axons in vivo (Moon et al., 2001; Bradbury et al., 2002).”
BackgroundSelf-citationMcKeon, R. J., Jurynec, M. J., & Buck, C. R. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-24-10778.1999 · Cited by 480 · cited 1×
“…proteoglycans (CSPGs) including NG2, neurocan, versican, aggrecan and brevican are present at sites of CNS injury, at least during the first month post-injury (Levine, 1994; McKeon et al., 1999; Jaworski et al., 1999; Asher et al., 2000; Lemons et al., 2001; Moon et al., 2001; Asher et al., 2002).”
Background
Cited by
Bringmann, A., Iandiev, I., Pannicke, T., Wurm, A., Hollborn, M., Wiedemann, P., Osborne, N. N., & Reichenbach, A. (2009) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.07.001 · Cited by 761
A Broader View: Microbial Enzymes and Their Relevance in Industries, Medicine, and Beyond
Gurung, N., Ray, S., Bose, S., & Rai, V. (2013) · BioMed Research International · doi:10.1155/2013/329121 · Cited by 687
Regenerative Therapies for Central Nervous System Diseases: a Biomaterials Approach
Tam, R. Y., Fuehrmann, T., Mitrousis, N., & Shoichet, M. S. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.237 · Cited by 293
The enzyme as drug: application of enzymes as pharmaceuticals
Vellard, M. (2003) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(03)00092-2 · Cited by 283
A ‘GAG’ reflex prevents repair of the damaged CNS
Sherman, L. S., & Back, S. A. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2007.11.001 · Cited by 116
Metadata
- Authors
- Moon, L. D. F., Asher, R. A., & Fawcett, J. W.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2002-10-09
- Volume
- 71
- Issue
- 1
- Pages
- 23-37
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2118233378
- Cited by
- 68
- References
- 2
- FWCI
- 1.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.